MarketWatch

Enara Bio Presents First-in-Class DARKFOX-Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential in Solid Tumor ...

The MarketWatch News Department was not involved in the creation of this content. -- First--in--class DARKFOX--targeting bispecific T cell engager: ENA101 is designed to selectively recognize the ...
MarketWatch

Enara Bio to Unveil First--in--Class DARKFOX--Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential for Solid Tumor ...

The MarketWatch News Department was not involved in the creation of this content. Oxford, UK -- March 17, 2026. Enara Bio, a pioneer in Dark Antigen(R) discovery and bispecific T cell engager ...